Fresenius Medical Care AG/€FME
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Fresenius Medical Care AG
Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.
Ticker
€FME
Sector
Primary listing
XETRA
Industry
Health Care Providers & Services
Headquarters
Employees
112,035
ISIN
DE0005785802
Website
FME Metrics
BasicAdvanced
€14B
22.69
€2.11
0.85
€1.44
3.01%
Price and volume
Market cap
€14B
Beta
0.85
52-week high
€54.02
52-week low
€32.51
Average daily volume
547K
Dividend rate
€1.44
Financial strength
Current ratio
1.461
Quick ratio
0.856
Long term debt to equity
61.316
Total debt to equity
69.79
Dividend payout ratio (TTM)
56.49%
Interest coverage (TTM)
3.91%
Profitability
EBITDA (TTM)
2,361.797
Gross margin (TTM)
24.46%
Net profit margin (TTM)
3.17%
Operating margin (TTM)
8.74%
Effective tax rate (TTM)
29.36%
Revenue per employee (TTM)
€170,000
Management effectiveness
Return on assets (TTM)
3.18%
Return on equity (TTM)
5.30%
Valuation
Price to earnings (TTM)
22.694
Price to revenue (TTM)
0.72
Price to book
0.91
Price to tangible book (TTM)
-8.79
Price to free cash flow (TTM)
8.243
Free cash flow yield (TTM)
12.13%
Free cash flow per share (TTM)
580.03%
Dividend yield (TTM)
3.01%
Forward dividend yield
3.01%
Growth
Revenue change (TTM)
0.10%
Earnings per share change (TTM)
27.83%
3-year revenue growth (CAGR)
2.77%
10-year revenue growth (CAGR)
2.43%
3-year earnings per share growth (CAGR)
-11.07%
10-year earnings per share growth (CAGR)
-4.09%
3-year dividend per share growth (CAGR)
2.17%
10-year dividend per share growth (CAGR)
5.13%
What the Analysts think about FME
Analyst ratings (Buy, Hold, Sell) for Fresenius Medical Care AG stock.
Bulls say / Bears say
Fresenius Medical Care reported stronger-than-expected first-quarter 2025 results, with revenues of €4.88 billion and adjusted operating income of €457 million, surpassing analysts' estimates. (reuters.com)
The company confirmed its 2025 outlook, anticipating U.S. market treatment growth to exceed 0.5% for the year, indicating confidence in future performance. (reuters.com)
Fresenius Medical Care's net income more than doubled in the first quarter of 2025, reaching €151 million, reflecting significant profitability improvements. (prnewswire.com)
The United Food and Commercial Workers Local 1776 health benefits fund filed a class action lawsuit against Fresenius Medical Care, alleging anti-competitive practices that inflated dialysis treatment costs. (reuters.com)
Fresenius Medical Care reduced its outlook for U.S. treatment volumes, now expecting flat to 0.5% growth, down from the previous 0.5% to 2% growth forecast, due to elevated patient mortality rates. (usnews.com)
Fresenius SE sold part of its stake in Fresenius Medical Care, reducing its ownership from 32.2% to 25% plus one share, leading to a 7.8% drop in FMC's stock price. (reuters.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
FME Financial Performance
Revenues and expenses
FME Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fresenius Medical Care AG stock?
Fresenius Medical Care AG (FME) has a market cap of €14B as of July 04, 2025.
What is the P/E ratio for Fresenius Medical Care AG stock?
The price to earnings (P/E) ratio for Fresenius Medical Care AG (FME) stock is 22.69 as of July 04, 2025.
Does Fresenius Medical Care AG stock pay dividends?
Yes, the Fresenius Medical Care AG (FME) stock pays dividends to shareholders. As of July 04, 2025, the dividend rate is €1.44 and the yield is 3.01%. Fresenius Medical Care AG has a payout ratio of 56.49% on a trailing twelve-month basis.
When is the next Fresenius Medical Care AG dividend payment date?
The next Fresenius Medical Care AG (FME) dividend payment date is unconfirmed.
What is the beta indicator for Fresenius Medical Care AG?
Fresenius Medical Care AG (FME) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.